Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;27(3):924-32.
doi: 10.1681/ASN.2015030243. Epub 2015 Jul 10.

Masked Uncontrolled Hypertension in CKD

Affiliations

Masked Uncontrolled Hypertension in CKD

Rajiv Agarwal et al. J Am Soc Nephrol. 2016 Mar.

Abstract

Masked uncontrolled hypertension (MUCH) is diagnosed in patients treated for hypertension who are normotensive in the clinic but hypertensive outside. In this study of 333 veterans with CKD, we prospectively evaluated the prevalence of MUCH as determined by ambulatory BP monitoring using three definitions of hypertension (daytime hypertension ≥135/85 mmHg; either nighttime hypertension ≥120/70 mmHg or daytime hypertension; and 24-hour hypertension ≥130/80 mmHg) or by home BP monitoring (hypertension ≥135/85 mmHg). The prevalence of MUCH was 26.7% by daytime ambulatory BP, 32.8% by 24-hour ambulatory BP, 56.1% by daytime or night-time ambulatory BP, and 50.8% by home BP. To assess the reproducibility of the diagnosis, we repeated these measurements after 4 weeks. Agreement in MUCH diagnosis by ambulatory BP was 75-78% (κ coefficient for agreement, 0.44-0.51), depending on the definition used. In contrast, home BP showed an agreement of only 63% and a κ coefficient of 0.25. Prevalence of MUCH increased with increasing clinic systolic BP: 2% in the 90-110 mmHg group, 17% in the 110-119 mmHg group, 34% in the 120-129 mmHg group, and 66% in the 130-139 mmHg group. Clinic BP was a good determinant of MUCH (receiver operating characteristic area under the curve 0.82; 95% confidence interval 0.76-0.87). In diagnosing MUCH, home BP was not different from clinic BP. In conclusion, among people with CKD, MUCH is common and reproducible, and should be suspected when clinic BP is in the prehypertensive range. Confirmation of MUCH diagnosis should rely on ambulatory BP monitoring.

Keywords: blood pressure; chronic kidney disease; hypertension.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Overview of study design. After a brief history and physical examination, participants had BP measured in a seated position. The technique of HBPM was explained and a self-inflating oscillometric device was dispensed. For one week, each participant recorded home BP twice daily. ABPM was performed over 24 hours. After one month hiatus, the study was repeated as in the initial month. CBP, clinic BP; HBPM, home BP monitoring.
Figure 2.
Figure 2.
Bivariate distribution of hypertension categories by visit. (A) Number of participants who had hypertensive clinic BP (left bar) or were normotensive (right bar). If clinic BP was in the hypertensive range, but ambulatory BP was normal isolated clinic hypertension (ICH) was diagnosed, or if ambulatory BP was high, they were said to have uncontrolled hypertension (UCH). If clinic BP was normal and ambulatory BP was normal they had controlled hypertension (CH), or if ambulatory BP was elevated they were diagnosed with MUCH. (B) The reason why participants were diagnosed with UCH or MUCH. UCH during daytime only (UCH-D), daytime or nightime (UCH-DN), or nighttime only (UCH-N) pie-chart is shown. Similarly MUCH breakdown as a pie chart by ambulatory BP monitoring elevation during daytime (MUCH-D), daytime or nighttime (MUCH-DN), and nighttime alone (MUCH-N) are shown. (C) and (D) Data from repeat measurements at week 4.
Figure 3.
Figure 3.
Receiver operating characteristic (ROC) curves for the diagnosis of MUCH). ROC curves for the diagnostic test performance of systolic clinic and home BP in predicting MUCH diagnosed by daytime ambulatory hypertension (135/85 mmHg) at baseline visit (A) and after 1 month (B). The area under the curve (AUC) for clinic and home BP monitoring were similar (P=0.38 and 0.14, respectively) at each of the two visits.

References

    1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1–12, 2003 - PubMed
    1. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047, 2007 - PubMed
    1. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 161: 1207–1216, 2001 - PubMed
    1. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G, Modification of Diet in Renal Disease Study Group : The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877–884, 1994 - PubMed
    1. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER, III, Norris K, O’Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT, Jr, Xu S, African American Study of Kidney Disease and Hypertension (AASK) Study Group : Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 285: 2719–2728, 2001 - PubMed

Publication types